GSK scales back workforce in neuroscience research

The transformation of GlaxoSmithKline from a company relying on a handful of expensive treatments to one dependent on consumer healthcare and emerging markets took a further step yesterday as it announced plans to scrap part of its neuroscience programme, with the loss of hundreds of jobs in the UK.

The chief executive, Andrew Witty, said the job losses were part of the drug-maker's "campaign to modernise" its research and development division. He added that focusing on returns for investors was not consistent with spending millions of pounds on treatments for conditions such as depression and anxiety, for which regulatory approval was notoriously difficult to obtain.

Mr Witty refused to give details of the numbers of jobs that would be lost throughout the company, but denied reports over the past week that GSK was preparing to lay off up to 4,000 staff in Britain. "Unlike other drugs companies, we are now facing fewer headwinds," he added. "We are happy that the strategy to change the focus of the company is on track. We are confident about the future."

Mr Witty's comments came as GSK announced its full-year results for 2009. It recorded a pre-tax profit, after restructuring costs, of £7.9bn, which was marginally ahead of its performance in 2008.

There had been speculation that GSK would follow rival AstraZeneca's announcement last week that it planned to shed 8,000 jobs by 2015.

Referring to the two firms being at different stages in the drug development cycle, and AstraZeneca facing comparatively greater generic competition, Mr Witty said: "We are a very different company in many ways."

GlaxoSmithKline has lost $4.5bn to generic competition over the past three years.

The research and development cuts form part of a plan to save £500m by 2012. Infrastructure savings and job losses in research and development will save £250m, with the rest coming from commercial activities, including sales and marketing.

Pandora's box: Witty praises patents policy

*The Government can do nothing to stop big pharmaceuticals companies cutting large numbers of jobs, but policies to attract the best scientific talent to Britain are working, Lord Drayson claimed last night.

The Science Minister said the global pharmaceuticals industry was coming under pressure in several areas but a number of companies had committed to investing in the UK. His comments came after Andrew Witty, the chief executive of GlaxoSmithKline, praised the Government for introducing the "patent box" in its pre-Budget report. The measure, taking effect in 2013, will cut to 10 per cent the corporation tax due on income derived from intellectual property registered in the UK.

Mr Witty said the policy was the biggest single reason why GSK would continue to invest heavily in Britain. Last week, he praised the Tories' economic policies but yesterday he denied that this amounted to a pre-election endorsement of David Cameron's party.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Financial Controller

£45 - £55k DOE: Guru Careers: A Financial Controller is required to join a suc...

Recruitment Genius: Sales Consultant / Telemarketer - OTE £20,000

£12500 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...

Recruitment Genius: Sales Adviser - OTE £24,500

£22500 - £24500 per annum: Recruitment Genius: Inbound and outbound calls with...

Recruitment Genius: Business Development Executive / Sales - OTE £40,000

£18000 - £40000 per annum: Recruitment Genius: This fast growing Insurance Bro...

Day In a Page

Mullah Omar, creator of the Taliban, is dead... for the fourth time

Mullah Omar, creator of the Taliban, is dead... again

I was once told that intelligence services declare their enemies dead to provoke them into popping up their heads and revealing their location, says Robert Fisk
Margaret Attwood on climate change: 'Time is running out for our fragile, Goldilocks planet'

Margaret Attwood on climate change

The author looks back on what she wrote about oil in 2009, and reflects on how the conversation has changed in a mere six years
New Dr Seuss manuscript discovered: What Pet Should I Get? goes on sale this week

New Dr Seuss manuscript discovered

What Pet Should I Get? goes on sale this week
Oculus Rift and the lonely cartoon hedgehog who could become the first ever virtual reality movie star

The cartoon hedgehog leading the way into a whole new reality

Virtual reality is the 'next chapter' of entertainment. Tim Walker gives it a try
Ants have unique ability to switch between individual and collective action, says study

Secrets of ants' teamwork revealed

The insects have an almost unique ability to switch between individual and collective action
Donovan interview: The singer is releasing a greatest hits album to mark his 50th year in folk

Donovan marks his 50th year in folk

The singer tells Nick Duerden about receiving death threats, why the world is 'mentally ill', and how he can write a song about anything, from ecology to crumpets
Let's Race simulator: Ultra-realistic technology recreates thrill of the Formula One circuit

Simulator recreates thrill of F1 circuit

Rory Buckeridge gets behind the wheel and explains how it works
Twitter accused of 'Facebookisation' over plans to overhaul reverse-chronological timeline

Twitter accused of 'Facebookisation'

Facebook exasperates its users by deciding which posts they can and can’t see. So why has Twitter announced plans to do the same?
Jane Birkin asks Hermès to rename bag - but what else could the fashion house call it?

Jane Birkin asks Hermès to rename bag

The star was shocked by a Peta investigation into the exotic skins trade
10 best waterproof mascaras

Whatever the weather: 10 best waterproof mascaras

We found lash-enhancing beauties that won’t budge no matter what you throw at them
Diego Costa biography: Chelsea striker's route to the top - from those who shared his journey

Diego Costa: I go to war. You come with me...

Chelsea's rampaging striker had to fight his way from a poor city in Brazil to life at the top of the Premier League. A new book speaks to those who shared his journey
Ashes 2015: England show the mettle to strike back hard in third Test

England show the mettle to strike back hard in third Test

The biggest problem facing them in Birmingham was the recovery of the zeitgeist that drained so quickly under the weight of Australian runs at Lord's, says Kevin Garside
Women's Open 2015: Charley Hull - 'I know I'm a good golfer but I'm also just a person'

Charley Hull: 'I know I'm a good golfer but I'm also just a person'

British teen keeps her feet on ground ahead of Women's Open
Turkey's conflict with Kurdish guerrillas in Iraq can benefit Isis in Syria

Turkey's conflict with Kurdish guerrillas in Iraq can benefit Isis in Syria

Turkish President Erdogan could benefit politically from the targeting of the PKK, says Patrick Cockburn
Yvette Cooper: Our choice is years of Tory rule under Jeremy Corbyn or a return to a Labour government

Our choice is years of Tory rule under Corbyn or a return to a Labour government

Yvette Cooper urged Labour members to 'get serious' about the next general election rather than become 'a protest movement'